UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
————————————————
FORM 8-K
————————————————
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 1, 2017
RPX Corporation
(Exact name of registrant as specified in its charter)
Delaware | 001-35146 | 26-2990113 | ||
(State or other Jurisdiction of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) | ||
One Market Plaza |
Suite 1100 |
San Francisco, CA 94105 |
(Address of principal executive offices, including zip code) |
(866) 779-7641 |
(Registrant’s telephone number, including area code) |
Not applicable |
(Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2): | ||
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||
o | Emerging growth company | |
o | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | |
Item 2.02 Results of Operations and Financial Condition.
On August 1, 2017, RPX Corporation (the "Company") issued a press release announcing its financial results for the second quarter ended June 30, 2017. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 1, 2017, Trevor Campion will cease serving as the Chief Executive Officer of RPX’s Inventus subsidiary. As of the date of this report, no new compensatory, separation or severance agreements have been entered into, and no existing compensatory arrangements have been materially amended or modified, in connection with Mr. Campion's departure.
Paul Mankoo, who has been President of Inventus since February of 2017, will succeed Mr. Campion as Chief Executive Officer of Inventus.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | ||
99.1 | Press release issued by RPX Corporation dated August 1, 2017 | ||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
RPX Corporation | ||
By: | /s/ EMILY T. GAVIN | |
Emily T. Gavin | ||
General Counsel | ||
Date: August 1, 2017
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Press release issued by RPX Corporation dated August 1, 2017 | |
EXHIBIT 99.1
RPX Announces Second Quarter 2017 Financial Results
SAN FRANCISCO – August 1, 2017 – RPX Corporation (NASDAQ: RPXC), the leading provider of patent risk and discovery management solutions, today announced its financial results for the second quarter ended June 30, 2017.
Highlights
Total revenue was $80.4 million, compared to $83.1 million in the second quarter of 2016.
• | Subscription revenue from patent risk management services—-including insurance—was $61.6 million, compared to $63.2 million in the prior year period. |
• | Discovery services revenue was $18.8 million, compared to $19.3 million in the prior year period. |
“We are pleased that our increased operational focus is already showing positive results, allowing us to exceed our adjusted EBITDA target on in-line revenues,” said Marty Roberts, Chief Executive Officer. “At the same time, we continue to develop strategic initiatives and opportunities to expand our service offering.”
Summary Results
GAAP net income for the second quarter was $4.2 million or $0.08 per diluted share, compared to $4.2 million or $0.08 per diluted share in the second quarter of 2016.
Non-GAAP net income for the second quarter, which excludes stock-based compensation, the amortization of acquired intangibles, fair value adjustments on deferred payment obligations, gains on extinguishment of deferred payment obligations, realized losses on exchange of short-term investments, and their related tax effects, was $9.2 million or $0.18 per diluted share, compared to $9.1 million or $0.18 per diluted share in the second quarter of 2016.
Non-GAAP adjusted EBITDA was $53.6 million for the second quarter of 2017, less net patent spend of $10.5 million, resulting in non-GAAP adjusted EBITDA less net patent spend, the Company's preferred measure of adjusted pre-tax free cash flow, of $43.1 million for the second quarter of 2017.
As of June 30, 2017, RPX's patent segment had more than 320 clients, consisting of patent risk management network members and insurance clients. The Company provides patent risk management services to more than 400 companies, including those insured under policies sold to venture funds and industry trade associations.
Net patent acquisition spend during the quarter totaled $10.5 million, and included 9 patent transactions.
As of June 30, 2017, RPX had cash, cash equivalents and short-term investments of $244.5 million and long-term debt of $91.7 million.
1
Inventus Management Change
Separately, the Company announced that Trevor Campion, CEO of its Inventus subsidiary, is leaving the Company effective August 1. Paul Mankoo has been promoted to CEO. Mankoo, who is currently President of Inventus, joined the Company as part of its acquisition of Unified in March 2015. Prior to becoming President, Paul headed Inventus's sales effort, so he is the ideal candidate to further the cross-selling program in place, along with managing day-to-day operations.
“We appreciate all of Trevor’s efforts during the integration of Inventus into RPX, and we wish him the best in his future endeavors,” said Marty Roberts. “I have worked closely with Paul since he was named President in February and I am delighted to partner with him as we continue to explore ways to leverage the strength of the RPX and Inventus combination, identifying ways to bring new cost efficiency to corporations.”
Business Outlook
This outlook reflects the Company’s current and preliminary view and may be subject to change. Please see the paragraph regarding “Forward-Looking Statements” at the end of this news release.
The Company provided the following business outlook for the third quarter of fiscal 2017:
Subscription and Discovery revenue[1] | $79 - $82 million | |
Fee-related revenue | $2 million | |
Total revenue | $81 - $84 million | |
Operating income (non-GAAP) | $12 - $14 million | |
Net income (non-GAAP) | $7 - $9 million | |
Consolidated adjusted EBITDA (non-GAAP) | $53 - $55 million | |
Effective tax rate (non-GAAP) | 35% | |
Weighted-average diluted shares outstanding | 50 million | |
The Company provided the following updated business outlook for the full year 2017:
Subscription revenue[1] | $243 - $250 million | |
Discovery revenue | $71 - $79 million | |
Fee-related revenue | $5 - $10 million | |
Total revenue | $319 - $339 million | |
Cost of revenue (non-GAAP) | $201 - $204 million | |
SG&A (non-GAAP) | $68 - $71 million | |
Operating income (non-GAAP) | $50 - $59 million | |
Net income (non-GAAP) | $32 - $38 million | |
Patent risk management adjusted EBITDA (non-GAAP) | $193 - $202 million | |
Discovery services adjusted EBITDA (non-GAAP) | $19 - $23 million | |
Total adjusted EBITDA (non-GAAP) | $212 - $225 million | |
Net patent spend | $110 - $115 million | |
Consolidated adjusted EBITDA less net patent spend (non-GAAP) | $97 - $115 million | |
Effective tax rate (non-GAAP) | 35% | |
Weighted-average diluted shares outstanding | 50 million | |
2
The Company provided the following updated supplemental information regarding amortization expense for the full year 2017:
Amortization of patent assets acquired through December 31, 2016 | $127 million | |
Amortization of patent assets to be acquired during fiscal 2017 | $32 - $34 million | |
Total amortization of patent assets | $159 - $161 million | |
Amortization of acquired intangible assets[2] | $8 - $9 million | |
————————
[1] | Subscription revenue is comprised of revenue generated from membership subscription services, premiums earned, net of ceding commissions, from insurance policies, and management fees related to the Company's insurance business. |
[2] | RPX excludes amortization expense related to intangible assets (other than patents) acquired in conjunction with the acquisition of businesses from its non-GAAP financial measures. |
The above outlook is forward-looking. Actual results may differ materially. The Company is not able, at this time, to provide a forward-looking reconciliation to GAAP outlook for the non-GAAP financial metric outlook it has provided above for the third quarter and full year 2017 because of the difficulty of estimating certain items that are excluded from the non-GAAP financial metrics, including those items listed in "Use of Non-GAAP Financial Information" below, the effect of which may be significant. Please refer to the information under the caption “Use of Non-GAAP Financial Information” below.
Conference Call
RPX management will host a conference call and live webcast for analysts and investors at 2:00 p.m. PDT/5:00 p.m. EDT on August 1, 2017. Parties in the United States and Canada can access the call by dialing 1-866-564-2842, using conference code 8515327. International parties can access the call by dialing 1-323-794-2130, using conference code 8515327.
The conference call will be webcast and investors will be able to access the webcast and slide presentation from the "Investor Relations" section of the company's website at www.rpxcorp.com. A replay of the webcast will be available online at the aforementioned website following the conclusion of the conference call.
About RPX
RPX Corporation (NASDAQ: RPXC) is the leading provider of patent risk management and discovery management solutions. Since its founding in 2008, RPX has introduced efficiency to the patent market by providing a rational alternative to litigation. The San Francisco-based company's pioneering approach combines principal capital, deep patent expertise, and client contributions to generate enhanced patent buying power. By acquiring patents and patent rights, RPX helps to mitigate and manage patent risk for its growing client network.
As of June 30, 2017, RPX had invested over $2 billion to acquire more than 18,000 US and international patent assets and rights on behalf of over 320 clients in eight key sectors: automotive, consumer electronics and PCs, E-commerce and software, financial services, media content and distribution, mobile communications and devices, networking, and semiconductors.
RPX subsidiary Inventus is a leading international discovery management provider focused on reducing the costs and risks associated with the discovery process through the effective use of technology solutions. Inventus has been providing litigation support services to corporate legal departments, law firms and government agencies since 1991.
Use of Non-GAAP Financial Information
This news release dated August 1, 2017 contains non-GAAP financial measures. Tables are provided in this news release that reconcile the historical non-GAAP financial measures to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures include non-GAAP cost of revenue, non-GAAP selling, general and administrative expenses, non-GAAP operating income, non-GAAP interest and other income (expense), net, non-GAAP net income, non-GAAP adjusted EBITDA, non-GAAP net income per share, and non-GAAP adjusted EBITDA less net patent spend.
3
To supplement the Company’s condensed consolidated financial statements presented on a GAAP basis, management believes that these non-GAAP measures provide useful information about the Company’s core operating results and thus are appropriate to enhance the overall understanding of the Company’s past financial performance and its prospects for the future. Management is excluding from some or all of its non-GAAP operating results (1) stock-based compensation expenses (inclusive of related employer payroll taxes), (2) the amortization of acquired intangible assets (other than patents), (3) fair value adjustments on deferred payment obligations, (4) gains on extinguishment of deferred payment obligations, (5) other-than-temporary impairment on short-term investments, (6) realized losses on exchange of short-term investments, and (7) their related tax effects.
Management uses these non-GAAP measures to evaluate the Company’s financial results and trends, allocate internal resources, prepare and approve our annual budget, develop short- and long-term operating plans, assess the health of our business and determine company-wide incentive compensation. Management believes these non-GAAP measures may prove useful to investors who wish to consider the impact of certain items when comparing the Company’s financial performance with that of other companies. The adjustments to the Company’s GAAP results are made with the intent of providing both management and investors a more complete understanding of the Company’s underlying operational results, trends and performance.
There are limitations in using non-GAAP financial measures because non-GAAP financial measures are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact on our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which items are adjusted to calculate our non-GAAP financial measures. Management compensates for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in our public disclosures.
The presentation of additional information should not be considered in isolation or as a substitute for or superior to financial results determined in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measure and not to rely on any single financial measure to evaluate our business.
Forward-Looking Statements
This news release and its attachments contain forward-looking statements within the meaning of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include the statements by management, statements regarding RPX’s future financial performance as well as any statements regarding the Company’s strategic and operational plans. The Company’s actual results may differ materially from those anticipated in these forward-looking statements. Factors that may contribute to such differences include, among others, the Company’s ability to maintain an adequate rate of growth, the success of the Company’s new initiatives, the Company's ability to integrate and manage the acquisition of Inventus Solutions, Inc., and the Company’s ability to attract new clients and retain existing clients. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” and similar expressions or variations intended to identify forward-looking statements. More information about potential factors that could affect the Company’s business and financial results is contained in the Company’s most recent annual report on Form 10-K, its quarterly reports on Form 10-Q, and the Company’s other filings with the SEC. The Company does not intend, and undertakes no duty, to update any forward-looking statements to reflect future events or circumstances.
# # #
Contacts:
Investor Relations | Media Relations |
JoAnn Horne | Jen Costa |
Market Street Partners | RPX Corporation |
+1 415-445-3233 | +1 415-852-3180 |
ir@rpxcorp.com | media@rpxcorp.com |
4
RPX Corporation | ||||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Revenue | $ | 80,434 | $ | 83,109 | $ | 162,946 | $ | 162,844 | ||||||||
Cost of revenue | 51,142 | 49,070 | 102,440 | 96,736 | ||||||||||||
Selling, general and administrative expenses | 23,124 | 25,904 | 44,245 | 52,799 | ||||||||||||
Operating income | 6,168 | 8,135 | 16,261 | 13,309 | ||||||||||||
Interest and other income (expense), net: | ||||||||||||||||
Interest income | 257 | 102 | 422 | 186 | ||||||||||||
Interest expense | (949 | ) | (883 | ) | (1,857 | ) | (1,233 | ) | ||||||||
Other income (expense), net | 1,119 | (768 | ) | 1,329 | 1,303 | |||||||||||
Total interest and other income (expense), net | 427 | (1,549 | ) | (106 | ) | 256 | ||||||||||
Income before provision for income taxes | 6,595 | 6,586 | 16,155 | 13,565 | ||||||||||||
Provision for income taxes | 2,403 | 2,436 | 5,970 | 5,178 | ||||||||||||
Net income | $ | 4,192 | $ | 4,150 | $ | 10,185 | $ | 8,387 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 0.09 | $ | 0.08 | $ | 0.21 | $ | 0.16 | ||||||||
Diluted | $ | 0.08 | $ | 0.08 | $ | 0.20 | $ | 0.16 | ||||||||
Weighted-average shares used in computing net income per share: | ||||||||||||||||
Basic | 49,142 | 51,034 | 48,910 | 51,548 | ||||||||||||
Diluted | 50,107 | 51,557 | 49,690 | 52,089 | ||||||||||||
5
RPX Corporation | |||||||
Condensed Consolidated Balance Sheets | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
June 30, 2017 | December 31, 2016 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 189,270 | $ | 100,111 | |||
Short-term investments | 55,271 | 90,877 | |||||
Restricted cash | 1,102 | 500 | |||||
Accounts receivable, net | 38,567 | 64,395 | |||||
Prepaid expenses and other current assets | 13,935 | 4,524 | |||||
Total current assets | 298,145 | 260,407 | |||||
Patent assets, net | 175,009 | 212,999 | |||||
Property and equipment, net | 6,294 | 6,948 | |||||
Intangible assets, net | 52,518 | 56,050 | |||||
Goodwill | 156,337 | 151,322 | |||||
Restricted cash, less current portion | 965 | 965 | |||||
Deferred tax assets | 34,042 | 38,261 | |||||
Other assets | 10,326 | 8,337 | |||||
Total assets | $ | 733,636 | $ | 735,289 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 2,468 | $ | 3,197 | |||
Accrued liabilities | 13,905 | 16,798 | |||||
Deferred revenue | 108,334 | 118,856 | |||||
Current portion of long-term debt | 7,724 | 6,474 | |||||
Other current liabilities | 1,008 | 1,484 | |||||
Total current liabilities | 133,439 | 146,809 | |||||
Deferred revenue, less current portion | 6,227 | 11,552 | |||||
Deferred tax liabilities | 3,830 | 4,023 | |||||
Long-term debt, less current portion | 83,935 | 88,110 | |||||
Other liabilities | 10,486 | 10,514 | |||||
Total liabilities | 237,917 | 261,008 | |||||
Stockholders’ equity: | |||||||
Common stock | 5 | 5 | |||||
Additional paid-in capital | 371,566 | 360,462 | |||||
Retained earnings | 134,730 | 130,249 | |||||
Accumulated other comprehensive loss | (10,582 | ) | (16,435 | ) | |||
Total stockholders’ equity | 495,719 | 474,281 | |||||
Total liabilities and stockholders’ equity | $ | 733,636 | $ | 735,289 | |||
6
RPX Corporation | |||||||
Condensed Consolidated Statements of Cash Flows | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
Six Months Ended June 30, | |||||||
2017 | 2016 | ||||||
Operating activities | |||||||
Net income | $ | 10,185 | $ | 8,387 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 85,855 | 85,585 | |||||
Stock-based compensation | 7,077 | 9,828 | |||||
Excess tax benefit from stock-based compensation | — | (33 | ) | ||||
Amortization of premium on investments | 890 | 972 | |||||
Deferred income taxes | 4,299 | 198 | |||||
Unrealized foreign currency (gain) loss | (1,047 | ) | 1,213 | ||||
Fair value adjustment on deferred payment obligations | — | (1,920 | ) | ||||
Gain on extinguishment of deferred payment obligation | — | (463 | ) | ||||
Realized loss on exchange of short-term investments | — | 290 | |||||
Other | 43 | 169 | |||||
Changes in assets and liabilities, net of business acquired: | |||||||
Accounts receivable | 26,761 | (15,207 | ) | ||||
Prepaid expenses and other assets | (11,342 | ) | (1,281 | ) | |||
Accounts payable | (961 | ) | 211 | ||||
Accrued and other liabilities | (3,015 | ) | (6,097 | ) | |||
Deferred revenue | (15,847 | ) | 7,379 | ||||
Net cash provided by operating activities | 102,898 | 89,231 | |||||
Investing activities | |||||||
Purchases of investments | (25,071 | ) | (31,150 | ) | |||
Maturities of investments | 59,820 | 42,393 | |||||
Sales of investments | — | 145,925 | |||||
Business acquisition, net of cash acquired | — | (228,453 | ) | ||||
Decrease (Increase) in restricted cash | (602 | ) | 225 | ||||
Purchases of property and equipment | (730 | ) | (2,087 | ) | |||
Acquisitions of patent assets | (41,918 | ) | (36,546 | ) | |||
Net cash used in investing activities | (8,501 | ) | (109,693 | ) | |||
Financing activities | |||||||
Proceeds from issuance of term debt | — | 100,000 | |||||
Payments of debt issuance costs | — | (2,003 | ) | ||||
Repayment of principal on term debt | (3,125 | ) | (1,250 | ) | |||
Proceeds from exercise of stock options | 5,894 | 247 | |||||
Taxes paid related to net-share settlements of restricted stock units | (3,291 | ) | (2,048 | ) | |||
Excess tax benefit from stock-based compensation | — | 33 | |||||
Payments of capital leases | (209 | ) | (236 | ) | |||
Repurchase of common stock | (4,783 | ) | (39,072 | ) | |||
Net cash provided by (used in) financing activities | (5,514 | ) | 55,671 | ||||
Foreign-currency effect on cash and cash equivalents | 276 | (152 | ) | ||||
Net increase in cash and cash equivalents | 89,159 | 35,057 | |||||
Cash and cash equivalents at beginning of period | 100,111 | 94,983 | |||||
Cash and cash equivalents at end of period | $ | 189,270 | $ | 130,040 | |||
7
RPX Corporation | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income Per Share | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net income | $ | 4,192 | $ | 4,150 | $ | 10,185 | $ | 8,387 | ||||||||
Stock-based compensation[1] | 4,479 | 4,976 | 7,354 | 9,998 | ||||||||||||
Amortization of acquired intangible assets[2] | 2,326 | 2,585 | 4,674 | 4,752 | ||||||||||||
Fair value adjustment on deferred payment obligations[3] | — | — | — | (1,920 | ) | |||||||||||
Gain on extinguishment of deferred payment obligations[3] | — | (463 | ) | — | (463 | ) | ||||||||||
Realized loss on exchange of short-term investments[3] | — | 188 | — | 188 | ||||||||||||
Income tax adjustments[4] | (1,764 | ) | (2,383 | ) | (3,403 | ) | (4,095 | ) | ||||||||
Non-GAAP net income | $ | 9,233 | $ | 9,053 | $ | 18,810 | $ | 16,847 | ||||||||
Non-GAAP net income per share: | ||||||||||||||||
Basic | $ | 0.19 | $ | 0.18 | $ | 0.38 | $ | 0.33 | ||||||||
Diluted | $ | 0.18 | $ | 0.18 | $ | 0.38 | $ | 0.32 | ||||||||
Weighted-average shares used in computing non-GAAP net income per share: | ||||||||||||||||
Basic | 49,142 | 51,034 | 48,910 | 51,548 | ||||||||||||
Diluted | 50,107 | 51,557 | 49,690 | 52,089 | ||||||||||||
RPX Corporation | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Cost of Revenue | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Cost of revenue | $ | 51,142 | $ | 49,070 | $ | 102,440 | $ | 96,736 | ||||||||
Stock-based compensation[1] | (126 | ) | — | (221 | ) | — | ||||||||||
Amortization of acquired intangible assets[2] | (531 | ) | (586 | ) | (1,056 | ) | (1,044 | ) | ||||||||
Non-GAAP cost of revenue | $ | 50,485 | $ | 48,484 | $ | 101,163 | $ | 95,692 | ||||||||
8
RPX Corporation | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Selling, General and Administrative Expenses | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Selling, general and administrative expenses | $ | 23,124 | $ | 25,904 | $ | 44,245 | $ | 52,799 | ||||||||
Stock-based compensation[1] | (4,353 | ) | (4,976 | ) | (7,133 | ) | (9,998 | ) | ||||||||
Amortization of acquired intangible assets[2] | (1,795 | ) | (1,999 | ) | (3,618 | ) | (3,708 | ) | ||||||||
Non-GAAP selling, general and administrative expenses | $ | 16,976 | $ | 18,929 | $ | 33,494 | $ | 39,093 | ||||||||
RPX Corporation | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Interest and Other Income (Expense), Net | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Interest and other income (expense), net | $ | 427 | $ | (1,549 | ) | $ | (106 | ) | $ | 256 | ||||||
Fair value adjustment on deferred payment obligation[3] | — | — | — | (1,920 | ) | |||||||||||
Gain on extinguishment of deferred payment obligations[3] | — | (463 | ) | — | (463 | ) | ||||||||||
Realized loss on exchange of short-term investments[3] | — | 188 | — | 188 | ||||||||||||
Non-GAAP interest and other income (expense), net | $ | 427 | $ | (1,824 | ) | $ | (106 | ) | $ | (1,939 | ) | |||||
RPX Corporation | |||||||||||||||
Reconciliation of Net Income to Non-GAAP Adjusted EBITDA Less Net Patent Spend | |||||||||||||||
(in thousands) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net income | $ | 4,192 | $ | 4,150 | $ | 10,185 | $ | 8,387 | |||||||
Provision for income taxes | 2,403 | 2,436 | 5,970 | 5,178 | |||||||||||
Interest and other (income) expense, net | (427 | ) | 1,549 | 106 | (256 | ) | |||||||||
Stock-based compensation[1] | 4,479 | 4,976 | 7,354 | 9,998 | |||||||||||
Depreciation and amortization | 42,926 | 41,030 | 85,855 | 85,585 | |||||||||||
Non-GAAP adjusted EBITDA[5] | 53,573 | 54,141 | 109,470 | 108,892 | |||||||||||
Net patent spend | (10,455 | ) | (20,885 | ) | (41,585 | ) | (37,134 | ) | |||||||
Non-GAAP adjusted EBITDA less net patent spend | $ | 43,118 | $ | 33,256 | $ | 67,885 | $ | 71,758 | |||||||
9
RPX Corporation | ||||||||
Additional Metrics | ||||||||
(in thousands, except client data) | ||||||||
(unaudited) | ||||||||
Three Months Ended June 30, | ||||||||
Operating Metrics | 2017 | 2016 | ||||||
Gross patent spend | $ | 10,455 | $ | 21,115 | ||||
Net patent spend | $ | 10,455 | $ | 20,885 | ||||
As of and for the Three Months Ended June 30, | ||||||||
Financial Metrics | 2017 | 2016 | ||||||
Subscription revenue[6] | $ | 61,583 | $ | 63,219 | ||||
Discovery revenue | 18,819 | 19,258 | ||||||
Fee-related revenue | 32 | 632 | ||||||
Total revenue | $ | 80,434 | $ | 83,109 | ||||
Cash, cash equivalents and short-term investments | $ | 244,541 | $ | 199,091 | ||||
Deferred revenue, current and non-current | $ | 114,561 | $ | 123,133 | ||||
[1] | RPX excludes stock-based compensation and related employer payroll taxes from its non-GAAP financial measures. |
[2] | RPX excludes amortization expense related to intangible assets (other than patents) acquired in conjunction with the acquisition of businesses from its non-GAAP financial measures. |
[3] | RPX excludes fair value adjustments and gains on extinguishment related to its deferred payment obligations and realized losses on |
exchanges of short-term investments from its non-GAAP financial measures.
[4] | Amount reflects income taxes associated with the above noted non-GAAP exclusions. |
[5] | RPX calculates non-GAAP adjusted EBITDA as GAAP earnings before other income or expenses, net, provision for income taxes, |
depreciation, amortization, and stock-based compensation expenses (inclusive of related employer payroll taxes).
[6] | Subscription revenue is comprised of revenue generated from membership subscription services, premiums earned, net of ceding commissions, from insurance policies, and management fees related to its insurance business. |
10